Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Derm CasesDermatology / Procedural Dermatology

Derm Cases · Dermatology / Procedural Dermatology

OSCE — intralesional corticosteroid counselling and technique

An 8-minute OSCE on selecting IL triamcinolone for keloid and patchy AA, concentration by site, technique endpoints, intervals, and safety counselling.

8 minosce1 min readVerification in progress

Target exams

NEET-PGINICETUSMLEPLABMRCP
On this page
Study tools

Target exams

NEET-PGINICETUSMLEPLABMRCP
Prompt
An 8-minute OSCE on selecting IL triamcinolone for keloid and patchy AA, concentration by site, technique endpoints, intervals, and safety counselling.

Brief (to candidate)

Clinic procedure room. A young adult has a shoulder keloid and two small AA patches. They want steroid injections today and ask if one session will “finish it.” You have 8 minutes to counsel and describe technique.

[11]

Candidate instructions

  1. Confirm indications and exclude infection/diagnostic doubt.
  2. Explain TAC concentration differences by site.
  3. Describe blanching endpoint and AA grid spacing.
  4. Give interval and need for serial sessions.
  5. Counsel atrophy/pigment change and rare systemic steroid risk.

Mark scheme (examiner)

DomainMarksExpected points
Selection2Keloid + limited AA appropriate; not infected
Concentration2Lower face/AA; higher thick keloid concept
Technique2Blanching aliquots; ~1 cm AA grid
Course2Every 3–6 weeks; multimodal keloid if needed
Safety2Atrophy/telangiectasia/hypopigmentation; rare systemic effects
[10]

Examiner notes

Fail if candidate promises one-injection permanent keloid cure or injects through obvious cellulitis.[10]

References7ShowHide
  1. [1]Richards RN. Update on intralesional steroid: focus on dermatoses. Journal of Cutaneous Medicine and Surgery, 2010.PMID 20128986
  2. [2]Fredman R, Tenenhaus M. Cushing's syndrome after intralesional triamcinolone acetonide: a systematic review of the literature and multinational survey. Burns, 2013.PMID 23092701
  3. [3]Walsh LA, Wu E, Pontes D, et al. Keloid treatments: an evidence-based systematic review of recent advances. Systematic Reviews, 2023.PMID 36918908
  4. [7]Mateos-Haro M, Novoa-Candia M, Sánchez Vanegas G, et al. Treatments for alopecia areata: a network meta-analysis. Cochrane Database of Systematic Reviews, 2023.PMID 37870096
  5. [9]Dakkak M, Forde KM, Lanney H. Hair Loss: Diagnosis and Treatment. American Family Physician, 2024.PMID 39283847
  6. [10]Zhuang Z, Li Y, Wei X. The safety and efficacy of intralesional triamcinolone acetonide for keloids and hypertrophic scars: A systematic review and meta-analysis Burns, 2021.PMID 33814214
  7. [11]Yin Q, Wolkerstorfer A, Lapid O, et al. KECORT Study: an international e-Delphi study on the treatment of keloids using intralesional corticosteroids in clinical practice Am J Clin Dermatol, 2024.PMID 39298112
PreviousOSCE — elliptical excision design and disease-specific marginsDermatology / Procedural DermatologyNextOSCE — safe cutaneous cryotherapy: indications, technique, freeze times, and complicationsDermatology / Procedural Dermatology